Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

250 results
Display

C-Peptide and Vascular Complications in Type 2 Diabetic Subjects

Son SM

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Prediction of Diabetes Using Serum C-Peptide

Jung HS

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
HLA Typing, Islet Cell Antibody and C-Peptide of Insulin Dependent Diabetes Mellitus in Children

Cho HR, Ko SJ, Kim DH, Lee HC, Huh KB

  • KMID: 1683669
  • J Korean Pediatr Soc.
  • 1990 Dec;33(12):1705-1712.
No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Improvement of Insulin Secretoruy Capacity According to Insulin Therapy in Non-Insulin Depentent Diabetes Mellitus

Kyung NH

To evaluate whether the urinary and serum c-peptide is the indicator of insulin therapy in NIDDM, and whether the insulin secretery capacity improves after control of blood glucose, We measured...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Letter: Basal C-peptide Level as a Surrogate Marker of Subclinical Atherosclerosis in Type 2 Diabetes Patients (Diabetes Metab J 2011;35:41-9)

Lee MS, Kim HJ

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Clinical characteristics of Korean insulin-dependent diabetes mellitus defined by serum C-peptide levels

Kim SW, Lee KU, Cheong SS, Kim HH, Park JY, Kim GS, Lee MH

  • KMID: 1698367
  • Korean J Med.
  • 1993 Dec;45(6):781-787.
No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Clinical characteristics of Korean diabetic patients classified by fasting plasma C-peptide level and degree of obesity

Lee KU, Ryu JS, Kim YT, Shong YK, Kim GS, Lee M, Park SW

  • KMID: 1698094
  • Korean J Intern Med.
  • 1992 Mar;42(3):315-321.
No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Correlations between Glucagon Stimulated C-peptide Levels and Microvascular Complications in Type 2 Diabetes Patients

Yoon HJ, Cho YZ, Kim JY, Kim BJ, Park KY, Koh GP, Lee DH, Lim DM

BACKGROUND: This study aimed to investigate whether stimulated C-peptide is associated with microvascular complications in type 2 diabetes mellitus (DM). METHODS: A cross-sectional study was conducted in 192 type 2 diabetic...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Clinical Utility and Cross-Reactivity of Insulin and C-Peptide Assays by the Lumipulse G1200 System

Oh J, Kim JH, Park HD

BACKGROUND: Measurement of insulin and C-peptide concentrations is important for deciding whether insulin treatment is required in diabetic patients. We aimed to investigate the analytical performance of insulin and C-peptide...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Estimation of Cut-off Point of Fasting Blood Glucose Predicting Pancreaticbeta-cell Decompensation During Oral Glucose Tolerance Test

Lee MD, Kim HS, Kim YU, Shin YG, Song CH, Won YJ, Chung CH

  • KMID: 2331695
  • J Korean Diabetes Assoc.
  • 1998 Dec;22(4):513-521.
BACKGROUND: The secretory dysfunction of pancreatic B-cell is one of the important in the pathogenesis of NIDDM. And the conversion from IGT to DM is developed by the exhaustion and...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Clinical Measures Associated with C-peptide Decline in Patients with Type 1 Diabetes over 15 Years

Lee TH, Kwon AR, Kim YJ, Chae HW, Kim HS, Kim DH

This study was done to characterize the natural course of C-peptide levels in patients with type 1 diabetes and identify distinguishing characters among patients with lower rates of C-peptide decline....
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Factors Related to Blood Intact Incretin Levels in Patients with Type 2 Diabetes Mellitus

Yoo S, Yang EJ, Koh G

BACKGROUND: We performed this study to identify factors related to intact incretin levels in patients with type 2 diabetes mellitus (T2DM). METHODS: We cross-sectionally analyzed 336 patients with T2DM. Intact glucagon-like...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Fasting Serum Glucose, Insulin and C-peptide Levels in Children with Obesity

Byun SH, Seo WH, Choi BM, Lee KH

  • KMID: 2193582
  • J Korean Soc Pediatr Endocrinol.
  • 2003 Jun;8(1):73-80.
PURPOSE:The prevalence of childhood obesity has been increased rapidly, associated with high morbidity of dyslipidemia, cardiovascular risk factors and insulin resistance/hyperinsulinemia. Hyperinsulinemia in obese children may depend on either increased...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Evaluation of C-peptide Test on Modular E170 Electrochemiluminescent Autoanalyzer

Lee SY, Hurh CB, Kang ES

  • KMID: 2200748
  • J Lab Med Qual Assur.
  • 2005 Dec;27(2):227-232.
BACKGROUND: C-peptide is a useful marker to differentiate the cause of hypoglycemia and assessment of beta cell secretory capacity in diabetes mellitus. On Modular E170 (E170, Roche Diagnostics, US), an...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Fasting serum C-peptide is useful for initial classification of diabetes mellitus in children and adolescents

Cho MJ, Kim MS, Kim CJ, Kim EY, Kim JD, Kim EY, Lee DY

PURPOSE: With rising obesity rates in children, it is increasingly difficult to differentiate between type 1 and type 2 diabetes mellitus (T1DM, T2DM) on clinical grounds alone. Using C-peptide as...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Clinical Types and Characteristics of Diabetes Mellitus in Korean Children

Yoo EG, Shin HJ, Kim DH

  • KMID: 2104500
  • J Korean Pediatr Soc.
  • 2000 Dec;43(12):1591-1598.
PURPOSE: Diabetic children should be classified into type 1 or 2 for adequate diabetic control. However, there is a shortage of information of the appropriate criteria in Korea. This study...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Association Between Fasting C-peptide and Gastrointestinal Symptoms of Gastroparesis in Type 2 Diabetic Patients

Huang Y, Zhang H, Zhang M, Li W, Wang J, Hu J

  • KMID: 2433526
  • J Neurogastroenterol Motil.
  • 2017 Apr;23(2):254-261.
  • doi: 10.5056/jnm16091
BACKGROUND/AIMS: The relationship between C-peptide levels and gastrointestinal (GI) symptoms in type 2 diabetic patients is not clear. The purpose of this study is to examine the association between fasting...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Factors Associated with C-peptide Levels after Diagnosis in Children with Type 1 Diabetes Mellitus

Hwang JW, Kim MS, Lee DY

C-peptide is the best indicator of endogenous insulin secretion in patients with diabetes. This study investigated the relationship between C-peptide levels and clinical/laboratory parameters of children with type 1 diabetes...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Preserved C-peptide levels in overweight or obese compared with underweight children upon diagnosis of type 1 diabetes mellitus

Yu HW, Lee YJ, Cho WI, Lee YA, Shin CH, Yang SW

PURPOSE: We hypothesized that overweight or obese children might develop type 1 diabetes mellitus (T1DM) early despite residual beta-cell function. Factors independently associated with preservation of C-peptide level were analyzed. METHODS:...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Peripheral Polyneruopathy and Hypoinsulinemia in Patients with Type 2 Diabetes

Jung YS, Lee KY, Lee SK, Kim HK, Park HY, Kang MH

  • KMID: 2177913
  • J Korean Diabetes Assoc.
  • 2000 Apr;24(2):256-266.
BACKGROUND: There is little information on the risk factors for diabetic polyneuro-pathy other than glycemic control and duration of diabetes. The relation between diabetic polyneuropathy and hypoinsulinemia is controversial. This...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr